| Literature DB >> 32753059 |
Jong Bin Bae1,2, Darren M Lipnicki3, Ji Won Han1,2, Perminder S Sachdev3,4, Tae Hui Kim5, Kyung Phil Kwak6, Bong Jo Kim7, Shin Gyeom Kim8, Jeong Lan Kim9, Seok Woo Moon10, Joon Hyuk Park11, Seung-Ho Ryu12, Jong Chul Youn13, Dong Young Lee2,14, Dong Woo Lee15, Seok Bum Lee16, Jung Jae Lee16, Jin Hyeong Jhoo17, Juan J Llibre-Rodriguez18, Jorge J Llibre-Guerra19,20, Adolfo J Valhuerdi-Cepero21, Karen Ritchie22,23, Marie-Laure Ancelin22, Isabelle Carriere22, Ingmar Skoog24, Jenna Najar24, Therese Rydberg Sterner24, Nikolaos Scarmeas25,26, Mary Yannakoulia27, Efthimios Dardiotis28, Kenichi Meguro29, Mari Kasai29, Kei Nakamura29, Steffi Riedel-Heller30, Susanne Roehr30, Alexander Pabst30, Martin van Boxtel31, Sebastian Köhler31, Ding Ding32,33, Qianhua Zhao32,33, Xiaoniu Liang32,33, Marcia Scazufca34, Antonio Lobo35,36,37, Concepción De-la-Cámara35,36,37, Elena Lobo35,36,37, Ki Woong Kim38,39,40.
Abstract
BACKGROUND: Dementia shows sex difference in its epidemiology. Childbirth, a distinctive experience of women, is associated with the risk for various diseases. However, its association with the risk of dementia in women has rarely been studied.Entities:
Keywords: Alzheimer’s disease; Dementia; Parity; Risk factors; Women
Mesh:
Year: 2020 PMID: 32753059 PMCID: PMC7406389 DOI: 10.1186/s12916-020-01671-1
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Contributing cohorts
| Study | Location | Start | Ethnicity* | Participants† (all/women/included) | Age‡ | Parity‡ | Dementia† (all/AD/VaD) |
|---|---|---|---|---|---|---|---|
| CHAS15 | Havana and Matanzas, Cuba | 2003 | Cuban | 2944/1913/1552 | 75.1 ± 7.2 (65–100) | 2.5 ± 2.2 (0–23)c | 183/105/11 |
| ESPRIT16 | Montpellier, France | 1999 | White | 2259/1313/1094 | 72.5 ± 5.6 (65–93) | 2.4 ± 1.5 (0–9)cb | 19/17/1 |
| H7017 | Gothenburg, Sweden | 2000 | White | 1016/787/575 | 74.7 ± 5.4 (70–92) | 2.0 ± 1.6 (0–20)c | 16/7/4 |
| HELIAD18 | Larissa and Marousi, Greece | 2009 | White | 1814/1074/918 | 72.1 ± 5.5 (60–93) | 2.0 ± 0.8 (0–7)cb | 22/16/3 |
| KLOSCAD19 | Nationwide, South Korea | 2010 | Asian | 6818/3919/3686 | 70.7 ± 7.2 (60–101) | 3.6 ± 1.7 (0–12)cb | 190/145/17 |
| KS20 | Kurihara, Japan | 2008 | Asian | 590/365/365 | 80.3 ± 4.2 (74–94) | 2.4 ± 1.3 (0–7)cb | 49/32/3 |
| LEILA 75+21 | Leipzig, Germany | 1997 | White | 1265/964/636 | 81.2 ± 4.9 (75–99) | 1.6 ± 1.3 (0–10)c | 68/48/14 |
| MAAS22 | South Limburg, Netherlands | 1993 | White | 683/342/342 | 69.2 ± 6.2 (60–82) | 2.6 ± 1.9 (0–9)c | 26/n.a./n.a. |
| SAS23 | Shanghai, China | 2010 | Asian | 3141/1873/1869 | 71.2 ± 8.4 (60–100) | 2.0 ± 1.4 (0–9)cb | 97/67/7 |
| SPAH24 | Sao Paulo, Brazil | 2003 | Brazilian | 2072/1255/1149 | 72.6 ± 6.4 (65–101) | 5.6 ± 4.1 (0–24)c | 68/24/13 |
| ZARADEMP25 | Zaragoza, Spain | 1994 | White | 4638/2683/2606 | 74.5 ± 9.6 (60–102) | 2.4 ± 1.9 (0–12)cb | 152/n.a./n.a. |
CHAS Cuban Health and Alzheimer Study, ESPRIT Etude Sante Psychologique et Traitement, H70 Gothenburg H70 Birth Cohort Studies, HELIAD Hellenic Longitudinal Investigation of Aging and Diet, KLOSCAD Korean Longitudinal Study on Cognitive Aging and Dementia, KS Kurihara Study, LEILA75+ Leipzig Longitudinal Study of the Aged, MAAS Maastricht Ageing Study, SAS Shanghai Aging Study, SPAH Sao Paulo Ageing & Health Study, ZARADEMP Zaragoza Dementia Depression Project, AD Alzheimer’s disease, VaD vascular dementia, n.a. not available
The participants of all studies but MAAS were randomly sampled.
*Ethnicity of the country
†Numbers at the baseline assessment
‡Mean ± standard deviations (range)
cNumber of children
cbNumber of childbirths
Comparison of the cohort characteristics between three geographical regions
| Characteristics | Total ( | Asia ( | Europe ( | Latin America ( | Statistics* | ||
|---|---|---|---|---|---|---|---|
| Post hoc* | |||||||
| Age, mean ± SD, years | 73.1 ± 7.9 | 71.4 ± 7.8 | 74.2 ± 8.0 | 74.0 ± 7.0 | 217.79 | < 0.001 | a < b, a < c |
| Educational level, % | 1049.72 | < 0.001 | – | ||||
| ≤ 6 years or primary school or under | 48.8 | 46.6 | 39.4 | 75.0 | |||
| 7 to 12 years or secondary school | 38.8 | 39.0 | 48.4 | 16.1 | |||
| > 12 years or tertiary school or above | 12.5 | 14.4 | 12.2 | 12.2 | |||
| Hypertension, % | 66.5 | 55.7 | 71.2 | 79.2 | 569.22 | < 0.001 | a < b, a < c, b < c |
| Diabetes mellitus, % | 17.3 | 16.6 | 12.7 | 29.5 | 375.205 | < 0.001 | a > b, a < c, b < c |
| Parity (continuous), mean ± SD | 2.8 ± 2.2 | 3.0 ± 1.8 | 2.3 ± 1.6 | 3.8 ± 3.5 | 512.99 | < 0.001 | a > b, a < c, b < c |
| Parity (categorical), % | 949.73 | < 0.001 | |||||
| 0 (nulliparity) | 9.8 | 4.5 | 14.3 | 11.2 | |||
| 1 to 4 | 74.6 | 77.8 | 77.9 | 60.2 | |||
| ≥ 5 (grand multiparity) | 15.6 | 17.8 | 7.8 | 28.6 | |||
| Dementia prevalence, % | 5.9 | 5.7 | 4.7 | 9.1 | 64.60 | < 0.001 | a < c, b < c |
| Dementia subtypes,† % | 54.14 | < 0.001 | – | ||||
| AD | 4.0 | 3.1 | 4.1 | 4.8 | |||
| VD | 0.6 | 0.7 | 0.5 | 0.9 | |||
| NAVD | 1.4 | 0.4 | 0.9 | 3.3 | |||
SD standard deviation, AD Alzheimer’s disease, VaD vascular dementia, NAVD non-Alzheimer non-vascular dementia
*Continuous variables were compared using analysis of variance, and categorical variables were compared using the χ2 test. Post hoc comparisons were based on Scheffé’s theorem: a = Asia; b = Europe; c = Latin America
†Estimated using 9 cohorts providing data on dementia subtypes
Comparison of the cohort characteristics between three parity groups
| Characteristics | Number of parities | Statistics* | ||||
|---|---|---|---|---|---|---|
| 0 | 1 to 4 | ≥ 5 | Post hoc* | |||
| Age, mean ± SD, years | 74 ± 8.3 | 72.3 ± 7.7 | 75.6 ± 7.7 | 224.345 | < 0.001 | a > b, a < c, b < c |
| Educational level, % | 1122.978 | < 0.001 | – | |||
| ≤ 6 years or primary school or under | 36.5 | 43.9 | 80.0 | |||
| 7 to 12 years or secondary school | 44.4 | 42.6 | 17.1 | |||
| > 12 years or tertiary school or above | 19.1 | 13.6 | 2.9 | |||
| Hypertension, % | 69.3 | 65.2 | 70.9 | 33.289 | < 0.001 | a > b, b < c |
| Diabetes mellitus, % | 13.1 | 16.5 | 23.5 | 84.376 | < 0.001 | a < b, a < c, b < c, |
| Dementia prevalence, % | 5.8 | 5.0 | 10.5 | 103.961 | < 0.001 | a < c, b < c, |
| Dementia subtypes,† % | 112.556 | < 0.001 | – | |||
| AD | 4.6 | 3.1 | 7.1 | |||
| VD | 0.6 | 0.5 | 1.1 | |||
| NAVD | 2.2 | 1.0 | 2.4 | |||
*Continuous variables were compared using analysis of variance, and categorical variables were compared using the χ2 test. Post hoc comparisons were based on Scheffé’s theorem: a = nulliparity; b = 1 to 4 parities; c = grand multiparity
†Estimated using 9 cohorts providing data on dementia subtypes
The risk of all-cause dementia associated with parity
| Parity | Number of subjects | Unadjusted model | Adjusted model I* | Adjusted model II† | ||||
|---|---|---|---|---|---|---|---|---|
| Control | Dementia | OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| 0 (nulliparity) | 1368 | 84 | 1.25 (0.93–1.68) | 0.014 | 0.91 (0.66–1.25) | 0.560 | 0.92 (0.67–1.27) | 0.613 |
| 1 (primiparity) | 2096 | 103 | 1.00 [Reference] | 1.00 [Reference] | 1.00 [Reference] | |||
| 2 | 3923 | 181 | 0.94 (0.73–1.20) | 0.618 | 1.12 (0.86–1.46) | 0.397 | 1.13 (0.86–1.47) | 0.375 |
| 3 | 2819 | 161 | 1.16 (0.90–1.50) | 0.245 | 1.19 (0.91–1.57) | 0.206 | 1.19 (0.91–1.57) | 0.200 |
| 4 | 1652 | 103 | 1.27 (0.96–1.68) | 0.096 | 1.06 (0.79–1.44) | 0.690 | 1.07 (0.79–1.45) | 0.664 |
| ≥ 5 (grand multiparity) | 2061 | 241 | 2.38 (1.87–3.02) | < 0.001 | 1.47 (1.11–1.94) | 0.007 | 1.47 (1.10–1.94) | 0.007 |
| 5 to 9 | 1836 | 212 | 2.35 (1.84–3.00) | < 0.001 | 1.43 (1.08–1.90) | 0.012 | 1.44 (1.08–1.90) | 0.012 |
| ≥ 10 | 225 | 29 | 2.62 (1.70–4.05) | < 0.001 | 1.84 (1.11–3.06) | 0.019 | 1.86 (1.11–3.09) | 0.018 |
OR odds ratio, CI confidence intervals
*Binary logistic regression analyses adjusted for age, educational level, and cohort as covariates
†Binary logistic regression analyses adjusted for age, educational level, hypertension, diabetes mellitus, and cohort as covariates
The risks of nulliparity and grand multiparity for dementia according to subtypes and geographical regions
| Numbers of subjects | All-cause dementia | AD | VaD | NAVD | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | Dementia | AD | VaD | NAVD | OR (95 CI)* | OR (95 CI)* | OR (95 CI)* | OR (95 CI)* | |||||
| Nulliparity | |||||||||||||
| Asia | 239/5584 | 27/336 | 17/244 | 1/27 | 7/54 | 2.15 (1.33–3.47) | 0.002 | 1.91 (1.07–3.39) | 0.028 | 1.03 (0.13–7.89) | 0.977 | 3.47 (1.44–8.35) | 0.005 |
| Europe | 117/3098 | 25/125 | 12/88 | 1/22 | 1/12 | 0.70 (0.38–1.30) | 0.261 | 0.90 (0.46–1.76) | 0.761 | 0.28 (0.04–2.13) | 0.218 | 0.53 (0.06–4.32) | 0.552 |
| Latin America | 2456/270 | 32/245 | 15/129 | 4/24 | 13/89 | 0.91 (0.59–1.40) | 0.661 | 0.72 (0.40–1.30) | 0.277 | 1.39 (0.42–4.57) | 0.585 | 1.11 (0.58–2.14) | 0.746 |
| Grand multiparity | |||||||||||||
| Asia | 919/5584 | 132/336 | 102/244 | 10/27 | 1/54 | 1.25 (0.94–1.67) | 0.122 | 1.29 (0.93–1.79) | 0.127 | 1.37 (0.55–3.42) | 0.498 | 1.22 (0.61–2.43) | 0.581 |
| Europe | 117/3098 | 39/125 | 6/88 | 3/22 | 1/12 | 2.99 (1.38–6.47) | 0.005 | 2.42 (0.94–6.25) | 0.068 | 6.86 (1.81–26.08) | 0.005 | 3.36 (0.37–30.80) | 0.283 |
| Latin America | 702/2456 | 70/245 | 30/129 | 9/24 | 28/89 | 1.49 (1.04–2.12) | 0.028 | 1.25 (0.77–2.03) | 0.366 | 1.41 (0.53–3.79) | 0.495 | 1.80 (1.05–3.10) | 0.034 |
AD Alzheimer’s disease, VaD vascular dementia, NAVD non-Alzheimer non-vascular dementia, OR odds ratio, CI confidence intervals
*Binary or multinomial logistic regression analyses that employed the women with 1 to 4 parities as the referent group and adjusted age, educational level, hypertension, diabetes mellitus, and cohort as covariates using the pooled dataset of 9 cohort studies that provided the type of dementia (Cuban Health and Alzheimer Study, Etude Sante Psychologique et Traitement, Gothenburg H70 Birth cohort Studies, Hellenic Longitudinal Investigation of Aging and Diet, Korean Longitudinal Study on Cognitive Aging and Dementia, Kurihara Study, Leipzig Longitudinal Study of the Aged, Shanghai Aging Study, Sao Paulo Ageing & Health Study)